Comparison of Speaker Role Recognition and Speaker Enrollment Protocol for conversational Clinical Interviews
Authors:
Rachid Riad,
Hadrien Titeux,
Laurie Lemoine,
Justine Montillot,
Agnes Sliwinski,
Jennifer Hamet Bagnou,
Xuan Nga Cao,
Anne-Catherine Bachoud-Lévi,
Emmanuel Dupoux
Abstract:
Conversations between a clinician and a patient, in natural conditions, are valuable sources of information for medical follow-up. The automatic analysis of these dialogues could help extract new language markers and speed-up the clinicians' reports. Yet, it is not clear which speech processing pipeline is the most performing to detect and identify the speaker turns, especially for individuals wit…
▽ More
Conversations between a clinician and a patient, in natural conditions, are valuable sources of information for medical follow-up. The automatic analysis of these dialogues could help extract new language markers and speed-up the clinicians' reports. Yet, it is not clear which speech processing pipeline is the most performing to detect and identify the speaker turns, especially for individuals with speech and language disorders. Here, we proposed a split of the data that allows conducting a comparative evaluation of speaker role recognition and speaker enrollment methods to solve this task. We trained end-to-end neural network architectures to adapt to each task and evaluate each approach under the same metric. Experimental results are reported on naturalistic clinical conversations between Neuropsychologist and Interviewees, at different stages of Huntington's disease. We found that our Speaker Role Recognition model gave the best performances. In addition, our study underlined the importance of retraining models with in-domain data. Finally, we observed that results do not depend on the demographics of the Interviewee, highlighting the clinical relevance of our methods.
△ Less
Submitted 5 November, 2020; v1 submitted 30 October, 2020;
originally announced October 2020.
Vocal markers from sustained phonation in Huntington's Disease
Authors:
Rachid Riad,
Hadrien Titeux,
Laurie Lemoine,
Justine Montillot,
Jennifer Hamet Bagnou,
Xuan Nga Cao,
Emmanuel Dupoux,
Anne-Catherine Bachoud-Lévi
Abstract:
Disease-modifying treatments are currently assessed in neurodegenerative diseases. Huntington's Disease represents a unique opportunity to design automatic sub-clinical markers, even in premanifest gene carriers. We investigated phonatory impairments as potential clinical markers and propose them for both diagnosis and gene carriers follow-up. We used two sets of features: Phonatory features and M…
▽ More
Disease-modifying treatments are currently assessed in neurodegenerative diseases. Huntington's Disease represents a unique opportunity to design automatic sub-clinical markers, even in premanifest gene carriers. We investigated phonatory impairments as potential clinical markers and propose them for both diagnosis and gene carriers follow-up. We used two sets of features: Phonatory features and Modulation Power Spectrum Features. We found that phonation is not sufficient for the identification of sub-clinical disorders of premanifest gene carriers. According to our regression results, Phonatory features are suitable for the predictions of clinical performance in Huntington's Disease.
△ Less
Submitted 31 July, 2020; v1 submitted 9 June, 2020;
originally announced June 2020.
